






1078–5884/00A Prospective Analysis of Fenestrated Endovascular
Grafting: Intermediate-term Outcomes
S. O’Neill, R.K. Greenberg,* F. Haddad, T. Resch, J. Sereika and E. KatzThe Department of Vascular Surgery, Cleveland Clinic Foundation, Cleveland, OH, USAPurpose. To assess the intermediate-term outcomes following fenestrated grafting for juxtarenal aneurysms.
Materials and methods. A prospective trial was conducted on patients with short proximal necks, who were considered to
be high-risk for open repair and unacceptable for conventional endovascular repair. Devices were designed from
reconstructed CT data. Follow-up studies included CT, duplex ultrasound, and KUB and occurred at hospital discharge, 1,
6, and 12 months and annually thereafter.
Results. One hundred and nineteen patients were treated (2001–2005). Mean age and aneurysm size were 75 years and
65 mm, respectively, and 82% were male. A total of 302 visceral vessels were inferior to the fabric seal (a mean of 2.5 vessels
per patient), with the most common design incorporating two renal arteries and the SMA (58%). All prostheses were
implanted successfully without any acute visceral artery loss. The mean follow-up was 19 months (0–42 months). One
patient died within 30 days of device implantation. Kaplan–Meier estimates of survival at 1, 12, 24, and 36 months are 0.99,
0.92, 0.83 and 0.79. There were no ruptures or conversions. Pre-discharge imaging noted 11 type I and type III endoleaks.
The 30-day endoleak rate was 10% (all type II). Aneurysm sac size decreased (O5 mm) in 51, 79 and 77% at 6, 12 and 24
months, respectively. One patient had sac enlargement within the first year, associated with a persistent type II endoleak. In-
stent stenoses occurred in 12 renal arteries and one SMA. Six renal arteries and the SMA stenosis were treated and two renal
stenoses are awaiting treatment. Ten of 231 stented renal arteries occluded (three prior to discharge), one of which was
recanalized. One component separation was treated with an extension at 2 years.
Conclusions. The placement of endovascular prostheses with graft material incorporating the visceral arteries is safe and
appears to be effective at preventing rupture. Continued follow-up to assess the long-term benefit, aneurysm sac behavior and
effect of stenting upon the visceral ostia remains critical..
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Patients presenting with abdominal aortic aneurysms
(AAA) being considered for endovascular aneurysm
repair are largely selected on anatomical criteria,
including proximal and distal neck diameter, length,
angulation and shape.1,2 Compromised proximal neck
anatomy is the most frequent rejection criteria for
treatment with endovascular prosthesis. Although
more robust proximal fixation systems, such as those
with barbs or uncovered suprarenal stents, may
provide improved device stability yet the need for a
sealing zone above the aneurysm must be considered
independent of the fixation. Maximizing the sealingthe Annual Meeting of the European Society for
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placement of the endoprosthesis into the immediate
infrarenal neck. Challenging proximal necks (such as
those with thrombus or surface irregularities), limi-
tations in visualizing the visceral vessel origin, as well
as technical issues associated with prosthesis deploy-
ment serve to limit the proximity of the proximal graft
material with respect to the renal arteries thus, limiting
the length of the intended sealing zone. Furthermore,
the behavior of sealing stents within a non-parallel or
irregular proximal neck is suboptimal. These issues
represent the impetus for the development of devices
capable of sealing above the renal arteries in the
setting of compromised proximal sealing zones.
The first reports of fenestrated devices were pub-
lished in 1999,3,4 and this was followed by the
development of a more versatile fenestrated device by
Anderson, Lawrence-Brown and Hartley.5,6 Additional
clinical experiences have been reported.7–9 This paper
updates our previously reported experiences8,10,11Eur J Vasc Endovasc Surg 32, 115–123 (2006)
doi:10.1016/j.ejvs.2006.01.015, available online at http://www.sciencedirect.com oned.
S. O’Neill et al.116including a substantially greater number of patients
with extended follow-up.Materials and Methods
Patients were prospectively enrolled in a physician-
sponsored investigational device exemption protocol
beginning in August 2001. For the purpose of this
publication, patient accrual terminated in June 2005
with follow-up through August of 2005. All patients
were deemed physiologically high-risk for open
surgical repair, and anatomically unsuitable for
traditional infrarenal endovascular grafts. Informed
consent, approved by our Institutional Review Board,
was obtained for all research subjects.
The pre-operative assessment of the aortic mor-
phology centered on high-resolution spiral CT-scans
incorporating the distal descending thoracic aorta
through the profunda femoral artery. Arteriography
was utilized sparingly, in general reserved for patients
with concomitant occlusive disease of the visceral or
pelvic vasculature. The Zenithe device (Cook Inc.,
Bloomington, Indiana) formed the foundation of the
fenestrated graft. The material construct and delivery
system are similar to the Zenithe which has been
previously described.10,12,13 Device planning required
accurate information regarding anatomic measure-
ments including the ostial diameter of each visceral
vessel, their relative distances from a fixed landmark
(typically the superior mesenteric artery), and their
radial orientation. Fenestrations were constructed to
match the ostial diameter and maximize the sealing
zone. Small fenestrations had a diameter between 6
and 8 mm, and were located at a minimum of 15 mm
distal to the top of the fabric top. The ostia for the small
fenestrations were placed between stent struts of the
aortic device, to allow unimpeded access into the
visceral artery, and intended for use in conjunction
with a balloon expandable stent within the target
vessel. Large fenestrations had greater diameters
(8–12 mm) with the potential of a strut crossing the
fenestration, and thus not intended for use with
additional stents. Scallop fenestrations were hemi-
ovals 6–12 mm in height and a 10 mm diameter
located at the most proximal portion of the fabric.Fig. 1. The aortic portion of the stent was initially flared with
a 10 mm balloon and subsequently with a latex compliant
balloon. This had the effect of both aligning and maximizing
the area of fenestration to wall contact.Implantation
Patients were anticoagulated with heparin
(100 units/kg) and activated clotting times were
maintained at greater than 300 s using additional
heparin. A stiff wire was placed into the ascendingEur J Vasc Endovasc Surg Vol 32, August 2006aorta through the intended main body delivery side,
while the contralateral side was double punctured, or
a large diameter valved sheath (Check Flo, Cook Inc.)
was placed allowing multiple sheaths (2–3) to be
placed within punctures made to the external valve. A
multisidehole flush catheter was placed through one
of the sheaths to visualize the renal arteries inter-
mittently using small bursts (5–7 cm3 at 30 cm3/s) of
non-ionic contrast. The proximal tubular fenestrated
endograft component was oriented using gold mar-
kers located on the device body and around each
fenestration. Partial deployment of this component
was followed by minute adjustments to properly
orient the fenestrations with their respective ostia
(Fig. 1). Access to main body was achieved from both
contralateral access ports, using selective catheteriza-
tion techniques. Visceral vessel access was then
established through the fenestrations, following
which sheaths or guides were placed into the desired
arteries. The posterior wire constraining the device to a
lesser diameter was then removed allowing the graft
to fully expand and the top cap was released. Balloon
expandable stents were chosen with a minimum of
17 mm in length and mounted upon a balloon sized to
the diameter of the intended visceral vessel. The stents
were deployed such that approximately 2/3 of the
stent was within the visceral vessel, and just less than
1/3 extended into the aorta (Fig. 2). The aortic portion
of the stent was then flared with a 10 mm balloon and
selectively flared further using a compliant latex
balloon. The second (bifurcated) component was
implanted ensuring a minimum of two stents of
overlap with the tubular component. The remainder




























Fig. 2. Thirty endoleaks were visualized on the pre-discharge
CT scan including seven type I and four type III endoleaks.
The rest were type II endoleaks. Our practice of aggressively
treating proximal type I and type III endoleaks in the post-
operative accounts for the low incidence of late type I
endoleaks.
Table 1. Pre-operative co-morbidities or risk factors for the 119
patient cohort
Patients (n) %
Congestive heart failure 17 14
Arterial hypertension 94 79
CABG/coronary stenting 58 49






Previous stroke 29 24
Fenestrated Endografts 117Patient follow-up
Post-operative evaluations were conducted at hospital
discharge, 1, 6, and 12 months and yearly thereafter.
Helical CT scans, duplex ultrasound (with the
exception of the discharge time point), creatinine
assessment, and flat plate radiography were obtained.
Secondary interventions were performed in the setting
of a suspected type I or III endoleak, selectively for
type II endoleaks, compromised visceral vessel flow,
or aneurysmal growth. When appropriate, outcome
analyses were conducted in accordance with the
reporting standards for endovascular aneurysm
repair.14 Elevation of serum creatinine was considered
significant if the serum value increased to greater than
2 mg/dl (180 mM) or a rise of O30% from baseline
levels was noted. Duplex determined end systolic and
diastolic velocities were collected for each visceral
vessel treated at each follow-up visit.Results
A total of 119 patients were treated. There were 98 men
and 21 women with a mean age of 75G7 years. The
pre-operative risk factors are listed in Table 1. The
mean diameter of the proximal neck was 26G3.5 mm
(range, 17–34 mm). The mean proximal neck length
was 8G4 mm (range, 3–18 mm). The proximal neck
length was !10 mm in 70 patients, and between 10
and 18 mm in 49 patients, all of which had morpho-
logic factors implying compromised sealing or fix-
ation. The shape of the neck was considered to have
an inverted funnel (nZ23), funnel (nZ23), irregular(nZ31), or parallel (nZ42) shape. Mean maximum
transverse diameter (MTD) of the AAA was 65G
11 mm (range, 46–102 mm). Regional anesthesia was
used in 97 cases and general anesthesia in 22 cases. A
total of 302 visceral vessels (Fig. 3) were incorporated
in the prosthesis design. Table 2 demonstrates the
distribution of renal, superior mesenteric and celiac
arteries treated.Procedure
All prostheses were successfully implanted. A conduit
to the common iliac artery (10 mm diameter polyester
vascular graft) was planned and performed in six
patients. Technical success was achieved in all cases
although in one case a single renal vessel was not
successfully catheterized and stented. This vessel was
patent at the completion of the procedure (angiogra-
phically), however, it occluded prior to the pre-
discharge CT scan. It was located within a tortuous
portion of a short proximal neck. Procedure time
averaged 227G76 min with a mean of 56G22 min of
fluoroscopy time. The mean volume of contrast
utilized was 179G53 ml. The mean blood loss was
739 ml.
The use of a large balloon expandable stent (Palmaz
stent, Cordis, Great Lakes, NJ) immediately below the
renal arteries was required in 23 patients to sup-
plement the seal, and a single patient was treated with
a proximal aortic cuff for a type I endoleak intraopera-
tively. Similarly, balloon expandable stents were also
deployed at the junction of the fenestrated component
and the bifurcated component in 14 patients and
extension grafts in two patients to treat modular joint
leaks intraoperatively (Fig. 4). Additional self-expand-
ing stents were implanted into seven iliac limbs to
alleviate kinking or unacceptable tortuosity following
endograft deployment. One patient required a femoral
endarterectomy and prosthetic patch closure on the
















Series1 65 62.3 58.3 51.4 50.9 50.2
Pre-op Post-op 1 Month 1 Year 2 Years 3 Years
Aneurysm Size Decrease >5 mm: 
6 Months = 51% 
1 Year = 79% 




Fig. 3.Mean aneurysm size decreased from a 65 mm pre-op. to 50 mm at 3 years. Looked at from a different perspective 51%
of patients had a decrease in aneurysm size of 5 mm or more at 6 months and this increased to almost 80% at 3 years.
Table 2. This table depicts the distribution of vessels incorporated
into the fenestrated devices used in this series
Mesenteric
fenestrations
Number of renal fenestrations
1 2 3
NONE 7 36 0
SMA 5 69 1
SMACCELIAC 0 1 0
The vast majority of patients (69%) had devices involving two main
renal arteries and the SMA. A single patient had a large accessory
renal that was preserved with a third renal fenestration, and two
patients had renal arteries that were markedly disparate, requiring
only single fenestrations. Only one patient required incorporation of
all four visceral vessels.
S. O’Neill et al.118Early follow-up (!30 days)
One patient died within 30 days (day 7) of the initial
procedure. This patient had bilateral common iliac
aneurysms and an attempted hypogastric bypass was
aborted due to difficult pelvic access (in a morbidly
obese male). The patient initially fared well; however,
he developed an ileus and suffered an aspiration
pneumonia, which further compromised his chronic
obstructive pulmonary disease. He ultimately died of
sepsis and multisystem organ failure.
Endoleak analysis
The post-procedural CT scan depicted a proximal type
I endoleak in six patients, a distal type I endoleak in
one patient, a type III endoleak in four patients and a
type II endoleak in 19 patients (Fig. 1). Four of six
patients with proximal type I endoleaks underwent
post-operative secondary procedures prior to hospital
discharge. Three were treated with a giant Palmaz
stent placed in the immediate infrarenal segment. The
first patient also required the placement of a balloon
expandable stent, which was placed within a right
renal artery that was not involved in the initial
fenestrated design. Another patient had a Jomed
covered stent placed into a left renal artery that was
stented in the initial fenestrated procedure, yet had
a persistent leak through the fenestration into the
aneurysm sac. The fourth patient did not have
anatomy amenable to additional stenting and,Eur J Vasc Endovasc Surg Vol 32, August 2006therefore, underwent glue embolisation of the leak
within the sac. All four treated endoleaks resolved and
none have recurred to date. Two patients with
proximal type I endoleaks were not treated prior to
hospital discharge and both resolved by the 1 month
CT scan. One sac remains excluded through 1 year of
follow-up, while the other sac demonstrated recur-
rence of the leak at the 12-month imaging study. The
patient then underwent a secondary procedure
involving placement of a proximal graft extension
and restenting of the left renal artery. The endoleak
resolved and has not recurred at the 24-month imaging
study. A distal type I endoleak at the left iliac limb was
treatedwith coil embolisation of the hypogastric artery
and an extension limb to the external iliac artery.




















Fig. 4.Kaplan–Meier estimate of the survival function for all-
cause mortality, with point-wise 95% confidence limits; the
ticks mark the censoring times. The survival function gives,
at each possible time from implantation, the probability of
surviving beyond that time.
Fenestrated Endografts 119junction of the tubular fenestrated and bifurcated
components during completion angiography, only
four of the untreated joint leaks remained after
intraoperative treatment to the pre-discharge CT
scan. Three of these were treated prior to hospital
discharge. One with an aortic extension cuff placed at
the overlap segment, the second a giant Palmaz stent,
and the third patient with a converter device followed
by a a femoral–femoral bypass when the endoleak
failed to resolve following the placement of two giant
Palmaz stents. All of these leaks were not present on
later follow-up (6 months, 2 years and 1 month). A
fourth type III endoleak was not treated, resolved
within 1 month and has not recurred through 1-year
follow-up. No type II endoleaks were treated in the
immediate post-operative period. An additional six
secondary procedures were performed in the early
post-operative period including a brachial artery
repair, repair of a femoral artery pseudo aneurysm, a
brachial artery thrombectomy, a femoral–distal bypass
and hallux amputation for a distal embolic events, and
evacuation of a groin hematoma.
Three stented renal arteries occluded prior to the
pre-discharge CT scan. In the first patient with a
severely angulated neck, the inability to gain wire
access to the renal artery precluded stenting of the
vessel. In the second patient a dissection occurred
during placement of the renal stent within a severely
diseased renal artery. Although recognized and
immediately treated with more distal stent placement,
the vessel thrombosed. The third patient had an
uncomplicated procedure but post-operatively was
noted to have a rising lactate and underwent
angiography, which revealed a patent SMA andoccluded right renal artery. A fourth patient had
patent renals at the pre-discharge CT scan, yet
occluded a renal artery when he represented 6 weeks
after implantation with a ruptured thoracic aortic
aneurysm and profound hypotension. The thoracic
rupture was successfully treated with another
endoprosthesis.Late follow-up (O30 days)
The mean follow-up was 19 months (range 0–48
months). Sixteen patients died during the follow-up
period, one within 30 days, seven within the first year,
and eight patients after 12 months of follow-up.
Kaplan–Meier estimates of survival at 1, 12, 24, and
36 months are 0.99, 0.92, 0.83 and 0.79, respectively
(Fig. 2). There were no late aneurysm related deaths
and no conversions to open procedures.
The 30-day endoleak rate was 10% (all type II
endoleaks). Sac shrinkage (O5 mm) was noted in 51%
(40/78) of patients at 6 months, in 79% (41/52) at 12
months and in 77% (23/30) of patients at 2 years. Mean
aneurysm size decreased from 65 mm post-op. to
50 mm at 3 years (Fig. 3). One patient demonstrated a
5 mm growth of his aneurysm at 1 year. This patient
had a type II endoleak at 1 month which was not seen
at 6 months but which was again visualized at the 12-
month follow-up visit. The patient refused treatment.
Other type II endoleaks were treated selectively in four
patients at 1, 1, 1 and 6 months, with glue embolisation
of the IMA and sac.Renal function
Forty-five patients (42%) had pre-operative creatinine
O1.2 mg/dl. Thirty patients (25%) developed at least a
transient increase in the serum creatinine of O30%
over the course of the follow-up period. Five of the six
renal artery stenoses treated to date were associated
with a transient rise in serum creatinine that uni-
versally improved following the secondary interven-
tion. All of the 10 patients with renal artery occlusions
demonstrated an increase in serum creatinine, four of
which ultimately required transient or permanent
dialysis. One of these patients with a right renal artery
occlusion diagnosed at the 1month imaging studywas
recanalised and restented but the patient remains on
dialysis.
A fifth patient who did not have a renal artery
occlusion but had chronic renal insufficiency pre-
operatively developed acute renal failure post-opera-
tively and expired prior to his 6-month review.Eur J Vasc Endovasc Surg Vol 32, August 2006
S. O’Neill et al.120Visceral vessel patency
In addition to the renal artery occlusions (nZ10) and
stenoses (nZ12) previously described (Fig. 4), a single
SMA stenosis manifested as persistent post-prandial
abdominal pain within 30 days following the pro-
cedure. Although no lesion was visualized by
angiography, intravascular ultrasonography per-
formed demonstrated fabric material partially
obstructing the SMA origin. This was treated with
angiography and stenting of the SMA. Duplex
ultrasonography at 6 months demonstrated no
evidence of restenosis and the patient is well. Duplex
ultrasonography depicted elevated velocities at the
origin of the SMA in a further two patients at 1 and 2
years post-procedure. Both patients are completely
asymptomatic and in one patient angiography for a
persistent type II endoleak did not visualize a stenosis
of the SMA. The second patient continues to be
observed.Discussion
Fenestrated endovascular grafts are designed to
extend the range of use of endovascular prosthesis
by moving the proximal sealing zone from the
infrarenal segment to the juxta and supra-renal aorta
thereby providing clinicians with the ability to treat
short infrarenal necks, properly align sealing zones in
the setting of angulated anatomy or complex neck
morphology. The fenestrations are necessary to
incorporate visceral vessels that encroach on the
desired sealing zone. Despite this ability, a segment
of relatively normal aorta that constitutes the proximal
neck is required, unlike a sister device which utilized
covered visceral artery stents to treat true suprarenal
or thoracoabdominal aneurysms.15,16
Successful results with a fenestrated graft require
appropriate patient selection, proper device design,
and technical expertise with endovascular grafting as
well as visceral vessel cannulation and stenting. The
absence of any one of these factors may result in
significant visceral vessel loss, aneurysms unprotected
from rupture risk, or the need for open surgical
conversion. For this reason, it is imperative that high-
resolution imaging studies be obtained and carefully
evaluated for acceptability. In addition to conventional
endovascular device sizing requirements, fenestrated
device design requires accurate distance calculations
to be made between the visceral vessels as well as the
correct location of the visceral vessel ostia from the
aortic circumference. With these data, one can design
a prosthesis that will incorporate the required vessels.Eur J Vasc Endovasc Surg Vol 32, August 2006When patient enrollment began in 2001 it was our
practice to perform both an axial CT and a pre-
operative diagnostic angiogram to gain sufficient
information regarding access vessel size and tortuos-
ity, neck angulation and the relative positions of the
renal and other visceral vessels to confidently and
accurately plan and size a custom device. Since mid
2003 with the more widespread availability of 3D
workstations, availing modalities such as 3D recon-
structions, centerline of flow measurement capability,
as well as the use of multilpanar reconstructions, the
need for pre-operative diagnostic angiography has
been supplanted. Nearly, all planning is based on
high-resolution CT using a 3D workstation.
Despite a proper device design, the implantation
procedure can be challenging. Complicating anatomic
factors include visceral vessel stenoses, iliac tortuosity
or calcifications that diminish the rotational freedom
of the device, and proximal neck angulation. It is
critical that clinicians understand the difference
between infrarenal and fenestrated devices. The
former devices require accurate longitudinal position-
ing during deployment. Error in achieving the desired
location, although undesirable, can be rectified with
the use of extension grafts. When implanting a
fenestrated device, the longitudinal position must be
accurate to within a few millimeters in addition there
is a need for precise rotational orientation (to allow
access into the visceral vessels). It is the rotational
positioning, which is thwarted by severe tortuosity or
occlusive disease, which limits torque that may be
applied to the proximal graft by rotating the delivery
system. This scenario occurred once early in our
experience and resulted in our inability to cannulate a
single renal artery ultimately causing in renal artery
thrombosis. Additional delivery concerns relate to the
potential for extensive manipulation of the device
within the proximal neck, particularly if atheroma is
present, may increase the risk of embolisation.
The need for protection of the renal ostia from graft
material management with stents extending through
the fenestration into the aorta and degree of flare has
been the subject of some discussion. Two types of
stents were utilized during the course of the study.
These included 0.035 and 0.014 in. systems. The larger
system (17 mm Double Strut, EV3, Plymouth, MN)
was used in the absence of renal disease (stenosis) and
with single renal arteries. This stent was associated
with adequate flaring properties as tested in out
laboratory. If significant renal occlusive disease was
present or should two renal stents be planned within
one fenestration as a result of multiple renal ostia, or
an early main renal artery bifurcation, the use of lower
profile system was desired and a stent with greater
Fenestrated Endografts 121radial force was delivered (Herculink, Guidant Inc.,
Menlo Park, California). The later stents were not
flared beyond the desired renal artery diameter.
Worsening renal function was noted in almost 25%
of patients and the loss of a number of renal arteries
are a significant concern. The majority of renal
occlusions occurred within the first month of follow-
up, and the remainder within the first year of follow-
up. Pre-operative device planning and delivery issues
were already discussed. Yet the majority of the renal
complications did not have a defined etiology.
The early appearance of renal dysfunction is likely
associated with either contrast nephropathy or ather-
oembolization, particularly in the setting of a neck
lined with atheroma. The increased manipulation of
the device within the pararenal aorta is a potential
cause. The need for extensive manipulation likely
decreases with the experience of the physicians, but all
must remain conscientious of this potential. In spite
of the noted renal impairment, no patient without
baseline renal insufficiency (GFR!60 ml/min) (Fig. 5)
required hemodialysis.11 We have struggled with
the application of renal and visceral vessel duplex
follow-up. Theoretically, ultrasound evaluations may
assist with the subclinical detection of stenoses, yet a
significant number of false positive duplex studies
were encountered. Current duplex guidelines rely
upon velocity measurements and ratios of such to
determine the severity of stenosis. The presence of an













Fig. 5.A total of 22 renal stenoses and occlusions occurred in the
renal artery occlusions. Overall five patients required either
patientswith renal artery occlusions.All patients that requireddiplaced to extend into the aortic lumen, create areas of
turbulence, and thus elevated velocities. Therefore,
these duplex studies reporting systolic velocity ratios
must be interpreted in the context of the clinical
situation, the procedural images and the follow-up CT
scans. A number of patients have been imaged
angiographically based upon elevated velocities
(some with a renal aortic ratio as high as 13) and
noted to have no aspect of stenosis on imaging studies
or with hemodynamic assessment (pressure gradient
assessment).
Despite the technical features allowing the more
proximal placement of graft material in the visceral
aortic segment, a number of proximal endoleaks were
still noted. This was found to be especially prevalent in
the setting of neck angulation. When detected these
intraoperative endoleaks were all treated during the
initial implantation with the superimposition of a
Palmaz stent (Cordis Inc.). This stent was deployed
below the renal artery stents and provides additional
radial force in the immediate infrarenal aorta. It also
has the effect of straightening excessive angulation to
some degree. Post-operatively, proximal type I endo-
leaks were aggressively addressed with Palmaz stents
or (in a single case) with aortic extension cuffs to
increase radial force. All such leaks have resolved and
none have recurred to date. The overall low incidence
of late type I leaks, supports the concept that the
extended sealing zone adequately excludes the aneur-
















course of follow-up including 12 renal artery stenoses and 10
intermittent or permanent dialysis and this includes four
alysis hadpreoperative renal insufficiency (GFR!60 ml/min.)
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S. O’Neill et al.122short proximal necks treated in this series. This is
further reinforced by relatively rapid the sac shrinkage
observed. Almost 80% of the patients have demon-
strated a decrease in aneurysm sac size by at least
5 mm ensuring that the natural history of the
aneurysmal disease is reversed.
Migrationwith a device that incorporates branches is
unacceptable. The current reporting standards for
endovascular aneurysm repair require device move-
ment of 10 mm or more, or the presence of a clinical
event caused by migration. This definition was revised
for our applications.17 Yet it appears that fenestrated
devices that migrate will result in massive renal or
visceral complications prior to reaching the requisite
distance of 10 mm. In this series, a single patient was
noted to have suffered devicemigration on the basis of a
required secondary renal intervention. The proximal
aspect of the device moved only 3 mm caudally, yet the
renal stent (which was initially placed into the middle
portion of the fenestration) was crushed causing a near
occlusion. The patient was treated with supplemental
renal stenting. This observation was previously
reported11 andbespeaks to the importanceof thefixation
systems. Furthermore, this prompted the placement of
the renal stents into the most caudal aspect of the
fenestration, to allow for slight downwardmovement of
the device as the hooks of the proximal fixation system
engage the aortic wall. Component separation occurred
in only one patient at 2 years, and this was treated with
an extension cuff. Extensive overlap between com-
ponents is encouraged to reduce the risk of this
uncommon complication. The multiple component
interfaces creates concern with respect to long-term
durability. Given the complex nature of the device,
meticulous imaging follow-up is mandatory such that
component separations, device migration, and stent
fracture can be detected and treated if necessary.Despite
the minimal occurrence of such events in this series, the
need for late follow-up of this patient cohort is
underscored to allow for more definite conclusions
regarding the durability of this repair.
Our results demonstrated that in the hands of an
experienced endovascular team, patients can be safely
treated despite proximal morphology previously
contraindicating an endovascular repair. Early post-
operative mortality was exceptionally low, secondary
interventions were relatively infrequent, while aneur-
ysm exclusion and sac shrinkage was common.
Attention to renal sequellae will be critical, as well as
judicious use of post-operative imaging studies to
assess the status of the sac. Our practice of aggres-
sively treating proximal type I and modular type III
endoleaks seems justified, but has been argued by
some to be unnecessary. The infrequency of migration,Eur J Vasc Endovasc Surg Vol 32, August 2006late visceral loss in the setting of favorable sac
behavior indicates that our belief that a stable sealing
and fixation site can be created within the pararenal
aorta is accurate through intermediate follow-up.Conflict of Interest Statement
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